Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

Sirle Saul(University of Tartu), Shirit Einav(Chan Zuckerberg Initiative (United States)), Marwah Karim(Stanford University), David E. Solow-Cordero(High Throughput Biology (United States)), Courtney Tindle(University of California San Diego), Pradipta Ghosh(University of Leeds), John M. Dye(United States Army Medical Research Institute of Infectious Diseases), Farhang Alem(George Mason University), John P. Wikswo(Vanderbilt University), Luca Ghita(Helmholtz Centre for Infection Research), Steven De Jonghe(Rega Institute for Medical Research), Kevin Chiem(Texas Biomedical Research Institute), Pieter Leyssen(Rega Institute for Medical Research), Jacquelyn A. Brown(University of Pittsburgh), Soumita Das(University of Massachusetts Lowell), Aarthi Narayanan(George Mason University), P. J. Huang(Stanford University), Ahmed Magdy Khalil(Zagazig University), Benjamin A. Pinsky(Stanford University), Verónica Durán(Medizinische Hochschule Hannover), Luis Martínez‐Sobrido(Texas Biomedical Research Institute), Sathish Kumar(Stanford University), Mamdouh Sibai(Stanford University), Dirk Jochmans(Rega Institute for Medical Research), Niloufar A. Boghdeh(George Mason University), Chieh‐Wen Lo(Stanford University), Winston Chiu(Rega Institute for Medical Research), Johan Neyts(Rega Institute for Medical Research), Jing Jin(Guangdong Province Women and Children Hospital), Nishank Bhalla(George Mason University), Courtney A. Cohen(United States Army Medical Research Institute of Infectious Diseases), Chengjin Ye(Texas Biomedical Research Institute), Kathleen E. Huie(United States Army Medical Research Institute of Infectious Diseases)
Journal of Clinical Investigation
August 15, 2023
Cited by 34


Related Papers